SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-188361
Filing Date
2019-07-03
Accepted
2019-07-02 17:47:33
Documents
4
Period of Report
2019-07-02
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d774603d8k.htm 8-K 20858
2 EX-3.1 d774603dex31.htm EX-3.1 27229
3 EX-3.2 d774603dex32.htm EX-3.2 106977
4 EX-99.1 d774603dex991.htm EX-99.1 5768
  Complete submission text file 0001193125-19-188361.txt   161984
Mailing Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110
Business Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110 857-449-2244
Karuna Therapeutics, Inc. (Filer) CIK: 0001771917 (see all company filings)

IRS No.: 270605902 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38958 | Film No.: 19939239
SIC: 2834 Pharmaceutical Preparations